PIEPER STEVEN (Chief Financial Officer) received a stock award from XERIS BIOPHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/3/2025ACC: 0001867096-25-000024
Officer· Chief Financial Officer
Since Oct 2021
+307.80K
Net shares
Net buyer
$630.8K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
485K acquired · 177.20K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−110.75K
Price / share
$3.56
Trade value
$394.27K
% of position
7.9%
1/31/2025
1.41M→1.30M
Common Stock
Direct
Shares
−66.45K
Price / share
$3.56
Trade value
$236.56K
% of position
5.1%
1/31/2025
1.30M→1.23M
Common Stock
Direct
Shares
+185K
Price / share
—
Trade value
—
% of position
15.0%
1/31/2025
1.23M→1.42M
Total
Net shares
+7.80K
Net value
-$630.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2025 | F · Tax Withholding | −110.75K | $3.56 | $394.27K | 7.9% | 1.41M | 1.30M |
| Common Stock Direct | 1/31/2025 | F · Tax Withholding | −66.45K | $3.56 | $236.56K | 5.1% | 1.30M | 1.23M |
| Common Stock Direct | 1/31/2025 | A · Award | +185K | — | — | 15.0% | 1.23M | 1.42M |
| Total | +7.80K | -$630.83K | ||||||
Derivative Transactions1
Stock Appreciation Right
Direct
Converts to
Common Stock
300K shares
Shares
+300K
Strike price
3.56
Held after
300K
Exercisable
—
1/31/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Appreciation Right Direct | Common Stock300K shares | 1/31/2025 | A · Award | +300K | 3.56 | — | 300K |